Table 1 Patient characteristics and clinicopathological features of the 20 gastric tumors used in the study
From: Up-regulation of CLDN1 in gastric cancer is correlated with reduced survival
Sex | Females n = 5, males n = 15 | |
Ethnicity | Caucasian n = 18, Asian n = 2 | |
Age at surgery | Total: 68.7 years (±12.5) | |
Females: 65.7 years (±21.8) | ||
Males: 69.7 years (±8.6) | ||
Postoperative survival (deceased individuals) | Total: 13.2 months (±8.8) | |
Females (n = 4): 16.6 months (±6.4) | ||
Males (n = 10): 12.0 months (±9.7) | ||
Postoperative survival (alive individuals at study end) | Total: 45.8 months (±7.9) | |
Females (n = 1): 48.0 months | ||
Males (n = 5): 44.9 months (±8.8) | ||
Tumor size | 49 mm (±27) | |
Tumor stage | T1 | 2 |
T2 | 10 | |
T3 | 5 | |
T4 | 3 | |
Nodal stage | N0 | 10 |
N1 | 5 | |
N2 | 3 | |
N3 | 2 | |
Histological type | Intestinal | 5 |
Diffuse | 12 | |
| Â | Mixed | 3 |